Clinical trial
Gliogene: Brain Tumor Linkage Study
NCT00418899 · M.D. Anderson Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00418899 |
|---|---|
| Title | Gliogene: Brain Tumor Linkage Study |
| Official title | Gliogene: Brain Tumor Linkage Study |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Brain Tumor, Glioma |
| Intervention type | Behavioral |
| Interventions | Questionnaire |
| Enrollment | 17,080 |
| Start date | Feb 12, 2004 |
| Primary completion | Sep 1, 2022 |
| Completion | Sep 1, 2022 |
| First posted | Jan 5, 2007 |
| Last update posted | Dec 31, 2020 |
| Countries | Denmark, Finland, Israel, Sweden, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: